# Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)

> **NCT00781573** · NA · COMPLETED · sponsor: **North Texas Veterans Healthcare System** · enrollment: 167 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT00781573
- **Lead sponsor:** North Texas Veterans Healthcare System
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-11
- **Primary completion:** 2014-03-03
- **Final completion:** 2014-03-03
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781573, "Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00781573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*